A new study points to specific changes companies can make in clinical trials so that, in the future, clearer data can lead us closer to a cure.
A new study looked specifically at rates of hospitalization for serious infections among people with lupus.
Kim Cantor, VP of Government Relations, provides an update on the Senate version of the 21st Century Cures Act that was passed in July 2015.
The research plan identifies and examines opportunities to increase scientific understanding of lupus, which will ultimately lead to safer and more effective treatments and, eventually, curative strategies
Anita Roach, Research Program Manager, reports on new lupus therapies and environmental aspects of lupus from American College of Rheumatology's Annual Scientific Meeting last week in San Francisco.
Anifrolumab significantly reduced disease activity as measured by several SLE composite endpoints and improved symptoms of lupus.
10th Anniversary of the Evelyn V. Hess Award Celebrates Past Honorees
Eight LFA-supported research studies presented during the American College of Rheumatology Annual Scientific Meeting